Case Study
Thursday, July 18
09:15 AM - 09:45 AM
Live in Singapore
Less Details
Digital transformation is enhancing biopharmaceutical manufacturing through automation, real-time data analysis, and predictive maintenance, leading to increased efficiency, quality, and agility in production processes. A data-driven approach enables Biopharmaceutical Manufacturers to identify potential issues early, improve process consistency, and ensure product quality throughout the manufacturing lifecycle. But how to start and how can compliance be assured? The presentation will tackle these issues
Presently a Director, Production (viral vaccines) at Serum Institute of India Pvt. Ltd., Pune, India. Head, Rabies, Polio and Japanese encephalitis vaccine departments. Trained in regulatory affairs at UMASS in Boston, USA and Chumakov Institute, Moscow, Russia. Guest lecturer in Stanford University. Dr. Ashish Sahai is also member of World Health Organization program, United against Rabies Forum and Zero by 2030.
Ex.IITian and has a Doctorate in biotechnology with more than 35 years of rich experience in various departments such as production, quality assurance, quality control in the Biotechnological industry and Research Institute. He has expertise in upstream processing as well as downstream processing of viral vaccines. He is specialized in purification of viral vaccines.